BALTIMORE, MD – October 1, 2023 --- We are excited to announce the expansion of our operations with the establishment of a new branch in China, named "KangPuBoAo (HangZhou) Biotechnology Inc." As a leading provider in the field of molecular disease diagnostics and multi-omics services, our new branch signifies a significant milestone in our commitment to global health advancements and our mission to deliver cutting-edge diagnostic solutions.
The establishment of KangPuBoAo (HangZhou) Biotechnology Inc. in China marks a significant step in our strategic expansion and reinforces our dedication to providing accessible, high-quality molecular diagnostics and multi-omics services on a global scale. This move not only enhances our ability to serve the Chinese market more effectively but also strengthens our position as a key player in the international healthcare sector.
Our new branch will leverage the latest advancements in molecular diagnostics and multi-omics technologies to offer a comprehensive range of services tailored to meet the unique needs of the Chinese market. We are committed to working closely with healthcare professionals, research institutions, and patients in China to contribute to the advancement of personalized medicine and improve health outcomes.
We look forward to the opportunities this expansion brings and are dedicated to establishing strong partnerships and collaborations in China to further our mission of transforming the future of healthcare through innovation and excellence in molecular diagnostics and multi-omics services.Diagnostics empowers people to take action to improve health outcomes.
For further information, please contact: Weiwei Hu, info@completeomics.cn or media@completeomics.com
